Cernostics receives $55,000 investment from Ben Franklin Technology Partners
Cernostics, a life science firm that develops and commercializes advanced cancer diagnostic tests, has received a $55,000 investment from Ben Franklin Technology Partners of Northeastern Pennsylvania. The funding will be used to validate a diagnostic...
Read more
